Condition
Revision
Total Trials
5
Recruiting
0
Active
2
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results67% success
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Active Not Recruiting2
Completed2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03423953Active Not Recruiting
Comprehensive Nano - Post Market Clinical Follow-Up Study
NCT07232771Completed
Reinfection and Re-revision Rates of Periprosthetic Knee Infection Under Four Different Surgical Strategies
NCT05002959Active Not Recruiting
TESS V3 Modular Total Shoulder System PMCF
NCT02865928Phase 4Terminated
Serratus Plane Block for Postoperative Pain Control
NCT03431857Completed
Multi Centre Study on TESS V2 Shoulder System
Showing all 5 trials